Ms. Jann Skinner - 18 Mar 2026 Form 3 Insider Report for Telix Pharmaceuticals Ltd (TLX)

Role
Director
Signature
/s/ Genevieve Ryan, on behalf of Ms. Jann Skinner
Issuer symbol
TLX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 20:47:19 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Skinner Jann Elizabeth Director C/O TELIX PHARMACEUTICALS LTD, 55 FLEMINGTON RD, NORTH MELBOURNE, AUSTRALIA /s/ Genevieve Ryan, on behalf of Ms. Jann Skinner 18 Mar 2026 0002121838

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TLX Ordinary Shares 595,000 18 Mar 2026 Forellan Pty Limited F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ms. Skinner is the sole director and shareholder of Forellan Pty Limited.

Remarks:

Ex. 24 - Power of Attorney